Flutiform Inhaler 125μg/5μg

Adult use

Adults (18 years and older): Depending on the severity of the condition, Flutiform inhaler 250μg/10 μg (fluticasone propionate 250 μg + formoterol 10 μg) should be administered as 2 metered doses inhaled twice a day. If asthma is well-controlled, a lower dose may be transitioned, and the dosage should be adjusted sequentially to the effective controlling dose.

Child use

Children aged 5 years and older: Depending on the severity of the condition, Flutiform inhaler 50μg/5μg (fluticasone propionate 50 μg + formoterol 5 μg) should be administered as 2 metered doses inhaled twice a day. 12 years

This medication is an inhaler used for the treatment of asthma and chronic obstructive pulmonary disease. This medication should not be used in certain patients. For example, it should not be administered to patients with allergies to this medication or its components, exacerbated asthma conditions, as the first treatment in acute asthma attacks, patients with moderate to severe bronchiectasis, and chronic obstructive pulmonary disease patients. Patients with heart diseases, thyroid problems, diabetes, hypokalemia, pulmonary tuberculosis, or pulmonary fungal infections should use this medication with caution. Particularly, patients with low serum potassium levels may experience worsening hypokalemia when using this medication, making serum potassium monitoring necessary. This medication helps control asthma symptoms, but a short-acting bronchodilator should be used during acute exacerbations, and it should not be used as a treatment for acute asthma attacks. Additionally, using high doses of this medication for long periods can result in side effects such as adrenal suppression, growth delay, decreased bone density, cataracts, and glaucoma, so it is important to use the minimum effective dose according to a doctor's instructions. When using this medication, it is advised to rinse the mouth with water to prevent oral infections like oral thrush, and to precisely follow the inhaler usage instructions. During pregnancy or breastfeeding, the necessity and risks of using this medication must be considered carefully, and its use is not recommended for children under 5 years of age. In case of overdose, symptoms such as irregular heartbeat, hypokalemia, tremors, headaches, nausea, insomnia, etc., may occur, so immediate consultation with medical personnel is necessary. This medication may interact with other drugs, so caution is needed, especially when taken with heart-related medications or CYP3A4 inhibitors. Finally, regular medical consultations are needed when using this medication to monitor asthma symptoms and lung function, and if symptoms worsen or abnormal reactions occur, consult medical personnel immediately.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, paleness, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, cough with fever accompanied abnormal respiratory issues, jaundice (yellowing of skin or eyes), extreme fatigue, sudden and severe headaches, thunderclap headaches, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

• Insomnia
• abnormal dreams
• restlessness
• psychomotor hyperactivity
• anxiety
• depression
• aggression
• behavior changes
• headaches
• tremors

This medication should be stored away from direct sunlight, and it is important to maintain a temperature below 25 degrees Celsius. It should not be placed in a refrigerator or freezer and should be stored in a sealed container to prevent air exposure.

Appearance

A metered-dose aerosol containing a white to off-white suspension in an aluminum container with a dose control valve.

Package unit

120 doses/can